Organizer
Evosep Biosystems
Evosep Biosystems
Evosep develops new solutions to make clinical proteomics 100 times more robust and 10 times faster. We are basing our design on years of experience with nano-UHPLC R&D and application support, critically rethinking the necessary system architectures for successful sample separation before mass spectrometric analysis.
Tags
LC/MS
LC/MS/MS
OMICS
LinkedIn Logo

Experimental Design Considerations for Scalable Proteomics

RECORD | Already taken place Th, 19.2.2026
This webinar will explore best practices for experimental design in LC-MS–based proteomics, with a focus on building robust, reproducible, and scalable workflows.
Go to the webinar
Evosep Biosystems: Experimental Design Considerations for Scalable Proteomics
Evosep Biosystems: Experimental Design Considerations for Scalable Proteomics

This webinar will explore best practices for experimental design in LC-MS–based proteomics, with a focus on building robust, reproducible, and scalable workflows. Topics will include key considerations for study design, sample throughput, and data quality, as well as practical strategies to maximize performance across diverse proteomics applications.

The session will combine real-world experience and technical insight to help researchers design experiments that deliver confident, actionable results.

Statistical aspects of experimental design in LC–MS–based proteomics
  • Olga Vitek, Raymond Bradford Bradstreet Professor and Director at the Barnett Institute

This presentation will discuss statistical principles of design and analysis of experiments, their application to LC-MS-based proteomics and chemoproteomics, and implementation in the free and open-source software ecosystem MSstats.

Design → QC → Scale: Best practices for robust, reproducible LC–MS proteomics workflows
  • Andrew Webb, Co-Founder & Chief Scientific Officer, Mass Dynamics

As LC–MS proteomics workflows become faster and more scalable, the bottleneck shifts from acquisition to experimental design, quality control, and consistent interpretation. In this talk we’ll share practical design patterns, throughput planning, and early‑warning metrics that catch drift and batch effects before they compromise a study. I’ll also highlight how high‑throughput LC (including Evosep workflows) pairs with standardised, automated reporting so teams can iterate quickly in pilots and then scale with confidence across diverse proteomics applications.

Evosep Biosystems
LinkedIn Logo
 

Related content

Oligonucleotide Analysis Using the Agilent InfinityLab Pro iQ and Altura Oligo HPH-C18 Column

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/SQ, Consumables, LC columns
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma

Simultaneous Quantitation and Discovery analysis: Combining targeted and untargeted metabolomics on Orbitrap mass spectrometers

Applications
| 2026 | Thermo Fisher Scientific
Instrumentation
LC/MS, LC/MS/MS, LC/Orbitrap, LC/HRMS
Manufacturer
Thermo Fisher Scientific
Industries
Metabolomics

Analysis of Per- and Polyfluoroalkyl Substances (PFAS) in Wastewater

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Agilent Technologies
Industries
Environmental

Non-Targeted Screening of Biosolids with the Xevo™ MRT Mass Spectrometer Reveals New Isoforms of PFAS

Applications
| 2026 | Waters
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Waters
Industries
Environmental

High Resolution Characterization of Lipid Nanoparticles Using the Xevo™ Charge Detection Mass Spectrometry (CDMS) Instrument - Single Particle Mass Analysis of Intact LNP-mRNA Formulations

Applications
| 2026 | Waters
Instrumentation
LC/MS, LC/MS/MS, LC/HRMS, Particle characterization, LC/IT
Manufacturer
Waters
Industries
Lipidomics
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike